Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aprotinin in cardiac surgery.

Neel R Sodha1, Munir Boodhwani, Cesario Bianchi

  • 1Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, LMOB 9B, Boston, MA 02215, USA. nsodha@bidmc.harvard.edu

Expert Review of Cardiovascular Therapy
|March 3, 2006
PubMed
Summary

Aprotinin, a protease inhibitor, reduces blood loss in cardiac surgery by inhibiting fibrinolysis and aiding hemostasis. It also offers anti-inflammatory benefits without increasing thrombosis risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redo-TAVR (TAV-in-TAV) Best Practices Part 1: Short-in-Short and Short-in-Tall - A Heart and Valve Collaboratory Document.

JACC. Cardiovascular interventions·2026
Same author

Redo-TAVR (TAV-in-TAV) Best Practices Part 2: Tall-in-Short and Tall-in-Tall - A Heart and Valve Collaboratory Document.

JACC. Cardiovascular interventions·2026
Same author

Left atrial appendage exclusion during open cardiac surgery in patients without atrial fibrillation reduces 4-year ischemic stroke and mortality.

JTCVS structural and endovascular·2026
Same author

Variation as a Symptom: What Hospital-Level TAVR Utilization Reveals About Lifetime Valve Planning.

The Annals of thoracic surgery·2026
Same author

Operating Room Extubation in Major Aortic Surgery: Policy Change Leading to Improved Recovery.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

The Legacy of the First Valve: Outcomes of Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Prior Surgical Aortic Valve Replacement-A Narrative Review.

Journal of clinical medicine·2026

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Surgery

Background:

  • Aprotinin is a naturally occurring serine protease inhibitor.
  • It is increasingly used in cardiac surgery to minimize blood loss and transfusion needs.
  • Aprotinin impacts the coagulation and fibrinolytic cascade.

Purpose of the Study:

  • To review the discovery and mechanism of action of aprotinin.
  • To discuss its dosing, adverse effects, and efficacy.
  • To highlight recent clinical trials demonstrating its benefits.

Main Methods:

  • Review of existing literature on aprotinin.
  • Analysis of its biochemical interactions within the coagulation and fibrinolytic systems.
  • Examination of data from major clinical trials.

Related Experiment Videos

Main Results:

  • Aprotinin inhibits serine proteases like plasmin, reducing fibrinolysis and promoting hemostasis.
  • It balances coagulation and fibrinolysis without elevating thrombosis risk.
  • Aprotinin exhibits anti-inflammatory properties beneficial during cardiopulmonary bypass.

Conclusions:

  • Aprotinin is an effective agent for reducing blood loss and transfusion requirements in cardiac surgery.
  • Its multifaceted action, including anti-inflammatory effects, supports its clinical utility.
  • Ongoing research and trials continue to validate its efficacy and safety profile.